Literature DB >> 1356799

Dose-dependent conditioned place preference produced by etonitazene and morphine.

M Sala1, D Braida, P Calcaterra, M P Leone, E Gori.   

Abstract

The conditioned place preference (CPP) paradigm was used to study the reinforcing properties of etonitazene in comparison with those of morphine. Increasing doses of etonitazene (2.5-15 micrograms/kg i.p.) and morphine (1-80 mg/kg i.p.) induced a dose-dependent CPP. High doses of etonitazene (25-40 micrograms/kg) did not elicit CPP. In addition, these reinforcing properties were related to behavioral modifications such as analgesia, assessed with the tail-flick method, and increased catalepsy, evaluated by a scoring system. It is concluded that neither the strong behavioral effects induced by etonitazene nor tolerance to such effects account for the results. These findings are discussed with regard to the possibility that etonitazene could interfere with associative learning motivated by reward.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356799     DOI: 10.1016/0014-2999(92)90508-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Authors:  Christian Doll; Florian Pöll; Kenneth Peuker; Anastasia Loktev; Laura Glück; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.

Authors:  Mark A Smith; Kara A Chisholm; Paul A Bryant; Jennifer L Greene; Jacob M McClean; William W Stoops; David L Yancey
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

3.  Oral etonitazene and cocaine consumption by AA, ANA and Wistar rats.

Authors:  P Hyyatiä; J D Sinclair
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.